Xcout Intel
Bonum Therapeutics, Inc. competitors & alternatives
The 8 closest competitors and alternatives to Bonum Therapeutics, Inc. among biopharma companies — ranked by similarity to what Bonum Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Bonum Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. is a startup holding company operating in the therapeutics and drug pipeline sector in Washington, United States.
Bonum Therapeutics, Inc. at a glance
Bonum Therapeutics, Inc. is a biopharma company headquartered in United States. Its most recent funding round raised $26.9M in April 2026. Xcout tracks 20 named people at Bonum Therapeutics, Inc., including John Mulligan (Chief Executive Officer).
Bonum Therapeutics, Inc. leadership
- John MulliganChief Executive Officer
- Diane HollenbaughChief Scientific Officer
- Neela PatelChief Business Officer
- Karl HandelsmanFounder & Managing Partner, Codon Capital
- Cindy YeeVice President, Corporate Strategy & Operations
- Justin Killebrew, PhDVice President of Biology
14 more named people on record for Bonum Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Bonum Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $26.9M | — | |
| SEC Form D filing | $45M | — | |
| Series A | $93M | — | |
| SEC Form D filing | $1.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 8 Bonum Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Bonum Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Drug Discovery
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Drug Discovery
Bridge Medicines LLC is a drug discovery holding company headquartered in New York, NY, that accelerates the path of therapeutic pipelines from research to patients.
Drug Discovery
Renibus Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Southlake, Texas, dedicated to transforming outcomes in specialty therapeutics and disease treatments.
Drug Discovery
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Drug Discovery
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Similar biopharma company
Good Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington. The firm focuses on drug discovery and the development of novel therapeutic pipelines and biopharmaceuticals.
Biopharmaceuticals
Altay Therapeutics, Inc. is a biotechnology company founded in 2019 and headquartered in the San Francisco Bay Area, California. The company focuses on developing therapeutics within the biotechnology sector.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Bonum Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Bonum Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →